IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`Serial No.: 14/885,965
`Attorney Docket No.: 44854-701303
`Page 1 /2
`
`In re the Application of:
`
`Inventors:
`
`William Banyai el al.
`
`Serial No.:
`
`14/885,965
`
`Filing Date: October 16, 2015
`
`Title: DE NOVO SYNTHESIZED
`GENE LIBRARIES
`
`
`
`Commissioner for Patents
`
`PO. Box 1450
`
`Alexandria, VA 22313-1450
`
`Group Art Unit:
`
`1798
`
`Confirmation No.:
`
`6374
`
`Customer No.:
`
`021971
`
`Patent No.
`
`US 10,272,410
`
`Date of Patent:
`
`April 30, 2019
`
`Gisele Metcalf
`
`Certificate of Electronic Filing
`I hereby certify that the attached communication and all marked
`attachments are being deposited by Electronic Filing on August 7,
`2019, by using the EFS — Web patent filing system and addressed to:
`Commissioner for Patents, PO. Box 1450, Alexandria, VA 22313 -
`1450.
`
`By:
`
`/Gisele Metcalf/
`
`REQUEST FOR CERTIFICATE OF CORRECTION OF THE ISSUED PATENT FOR
`OFFICE MISTAKE 137 C.F.R. § 1.322!
`
`Dear Commissioner:
`
`It is noted that an error appears in the above identified patent due to a mistake on the part
`
`of the Office, as more fully described below. The Patentee believes that correction thereof does
`
`not involve such changes in the patent as would constitute new matter or would require re-
`
`examination of the patent. A certificate of correction is therefore requested.
`
`Attached hereto is Form PTO/SB/44 which is suitable for printing.
`
`Patentee respectfully requests the Letters Patent be corrected as shown below:
`
`Column 235, line 50, Claim 1, the portion “wherein each molecule of the first set
`of molecules is an aminosilane or N-(3 -triethoxvsilvlpropyD-
`4hydroxybutvramide.”
`
`should read — wherein each molecule of the first set of molecules is an
`
`

`

`Serial No.: 14/885,965
`Attorney Docket No.: 44854-701303
`Page 2 / 2
`
`aminosilane or N-(3 -triethoxysilylpropyl)-4-hydroxybutyramide. --
`
`Support for the correction to claim 1 can be found in the Amendment to Claim 21 filed
`
`via EFS-Web on November 28, 2018, and referenced incorrectly by the Office on page 2 of the
`
`Notice of Allowability mailed December 14, 2018. Correction to claim 1 is to correct claim to
`
`be consistent with Claim 21 as amended in the November 28, 2018 posting.
`
`There is no fee for the submission of this letter. However, the Commissioner is
`
`authorized to charge any fees which may be required or credit any overpayment to Deposit
`
`Account No. 23-2415 (Docket No. 44854-701303).
`
`Respectfully submitted,
`
`WILSON SONSINI GOODRICH & ROSATI
`
`Date: August 7, 2019
`
`By:
`
`/Diana G. Hendricks/
`Diana G. Hendricks
`
`Reg. No. 74,614
`
`650 Page Mill Road
`Palo Alto, CA 94304
`Phone: (617) 598-7824
`Fax: (650) 493-6811
`Customer No. 021971
`
`

`

`PTO/SB/44 (09-07)
`Approved for use through 08/31/2010. OMB 0651-0033
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`Also Form PTO-1050
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`CERTIFICATE OF CORRECTION
`
`PATENT NO.
`
`APPLICATION NO.
`
`ISSUE DATE
`
`INVENTOR(S)
`
`:
`
`:
`
`:
`
`:
`
`10,272,410
`
`14/885,965
`
`April 30, 2019
`
`Page 1 of]
`
`William Banyai, Bill James Peck; Andres Fernandez; Siyuan Chen; Pierre Indermuhle
`
`4-hydroxybutyramide. --
`
`It is certified that an error appears or errors appear in the above-identified patent and that said Letters Patent
`is hereby corrected as shown below.
`
`Column 235, line 50, Claim 1, the portion “wherein each molecule of the first set of molecules is an aminosilane
`or N-(3-triethoxvsiIvlpropyD-4hydroxybutvramide.”
`
`should read — wherein each molecule ofthe first set of molecules is an aminosilane or N-(3-triethoxysilylpropyl)-
`
`MAILING ADDRESS OF SENDER: (Please do not use customer number below)
`Wilson Sonsini Goodrich & Rosati
`
`650 Page Mill Road
`Palo Alto, California 94304
`This collection of information is required by 37 CFR 1.322, 1.323, and 1.324. The information is required to obtain or retain a benefit by the public which is to file
`(and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 1.0 hour to
`complete, including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any
`comments on the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer,
`US. Patent and Trademark Office, US. Department of Commerce, PO. 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS
`TO THIS ADDRESS. SEND TO: Attention Certificate of Corrections Branch, Commissioner for Patents, P.0. Box 1450, Alexandria, VA 22313-1450.
`
`If you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.
`
`10922727
`
`